GlassScriptPhysician profile
Elizabeth Wist
NPI 1720226863
$9,013.31
in general payments reported to CMS, 2019-2025
18 companies · $3,931 in 2025
The $3,931 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $347 · 2022: $47.41 · 2023: $55.59 · 2024: $4,632 · 2025: $3,931.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,481 · Travel and Lodging: $2,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,481.10 |
| Travel and Lodging | $2,138.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,679.17 | 2024-2025 | Sapien 3 Ultra Resilia, Evoque, Konect Resilia |
| Abbott Laboratories | $1,998.77 | 2024-2025 | Mitraclip, Navitor, Triclip |
| Medtronic, INC. | $729.26 | 2024-2025 | Corevalve Evolut R |
| Aop Health US, LLC | $509.74 | 2025 | Rapiblyk |
| Cardiva Medical, INC. | $176.73 | 2024-2025 | Savvywire, Cardiva Vascade 6/7f Vcs |
| Pfizer INC. | $152.07 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $149.95 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $147.27 | 2021-2025 | Eliquis |
| Abiomed | $146.10 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $80.38 | 2021 | |
| Integra Lifesciences Corporation | $78.76 | 2023-2024 | Codman Certas, Cusa Clarity, Codman Hakim |
| Irhythm Technologies, INC. | $34.15 | 2024 | Zio Xt Patch, Zio Monitor |
| Guard Medical INC. | $29.66 | 2025 | Npseal |
| Philips North America LLC | $25.60 | 2025 | Extended Holter |
| Daiichi Sankyo INC. | $23.83 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.02 | 2023 | Jardiance |
| Amgen INC. | $16.60 | 2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $16.25 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Wist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.